Literature DB >> 1453267

Retinoblastoma and p53 gene expression related to relapse and survival in human breast cancer: an immunohistochemical study.

A Sawan1, B Randall, B Angus, C Wright, J A Henry, J Ostrowski, C Hennessy, T W Lennard, I Corbett, C H Horne.   

Abstract

Inactivation of tumour suppressor genes may be an important aetiological factor in many human cancers including breast. In a study of 197 breast cancer patients, tumour tissue was snap-frozen at the time of surgery and immunohistochemical labelling for p53 protein and retinoblastoma (Rb) gene product carried out using an indirect immunohistochemical technique. Tumours were scored by two independent observers for the intensity of nuclear staining for each antibody. Expression of p53 protein showed a significant association with a shorter time to relapse (P = 0.03) and death (P = 0.02) (log rank test). p53 expression did not correlate with nodal status but showed a significant association with high tumour grade (P = 0.001). Rb gene expression showed no relationship to relapse or survival but loss of expression showed a significant correlation with positive lymph node status. The manner by which these proteins might act to determine tumour behaviour remains to be established.

Entities:  

Mesh:

Year:  1992        PMID: 1453267     DOI: 10.1002/path.1711680105

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  13 in total

1.  Immunohistochemical study of Cell Cycle Modulators in G(1)-S Transition in Clinical Breast Cancer Tissue.

Authors: 
Journal:  Breast Cancer       Date:  1996-06-28       Impact factor: 4.239

2.  Biological indices in the assessment of breast cancer.

Authors:  A S Leong; A K Lee
Journal:  Clin Mol Pathol       Date:  1995-10

3.  Analysis of phosphorylation of pRB and its regulatory proteins in breast cancer.

Authors:  E Wakasugi; T Kobayashi; Y Tamaki; Y Nakano; Y Ito; I Miyashiro; Y Komoike; M Miyazaki; T Takeda; T Monden; M Monden
Journal:  J Clin Pathol       Date:  1997-05       Impact factor: 3.411

4.  Retinoblastoma (RB1) gene product expression in breast carcinoma. Correlation with Ki-67 growth fraction and biopathological profile.

Authors:  C Ceccarelli; D Santini; P Chieco; M Taffurelli; M Gamberini; S A Pileri; D Marrano
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

5.  Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.

Authors:  V G Gorgoulis; E N Koutroumbi; A Kotsinas; P Zacharatos; C Markopoulos; L Giannikos; V Kyriakou; Z Voulgaris; I Gogas; C Kittas
Journal:  Mol Med       Date:  1998-12       Impact factor: 6.354

6.  P53 protein in 204 patients with primary breast carcinoma--immunohistochemical detection and clinical value as a prognostic factor.

Authors:  U J Göhring; A Scharl; C Heckel; A Ahr; G Crombach
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

7.  A flow cytometric study of c-erbB-3 expression in breast cancer.

Authors:  I Brotherick; B K Shenton; B Angus; I S Waite; C H Horne; T W Lennard
Journal:  Cancer Immunol Immunother       Date:  1995-11       Impact factor: 6.968

8.  Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.

Authors:  K I Bland; M M Konstadoulakis; M P Vezeridis; H J Wanebo
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

Review 9.  The clinical significance of p53 aberrations in human tumours.

Authors:  S Bosari; G Viale
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Quantitative analysis of mutant p53 protein in breast tumor cytosols and study of its association with other biochemical prognostic indicators in breast cancer.

Authors:  M A Levesque; E P Diamandis; H Yu; D J Sutherland
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.